No Detail Found!

Sera Levels of microRNA-124 in Newly Diagnosed Patients with Type 2 Diabetes Mellitus in Iraqi Population

Author(s)
Huda B. Al-Lami Department of Chemistry and Biochemistry, Faculty of Medicine, University of Maysan
Ramzi ZEMNI Department of Genetics, and Biochemistry Faculty of Medicine University of Soussa
Ammar Gany Yassin Department of Biochemistry, Faculty of Medicine, University of Kerbala
Abstract
Recently, circulating microRNAs (miRNAs) have emerged as potential new biomarkers for diagnosing and prognosis a wide range of disorders. The study aimed to compare the sera levels of miRNA21 and miRNA124 among newly diagnosed patients e with type 2 diabetes mellitus (T2DM) patients with their levels in apparently healthy subjects using blood samples. The time frame for this case-control research is August 2022 through March 2023, and it took place at AlSadr Teaching Hospital/Madina in Masin. One hundred patients with a recent di recently patients with T2DM (50 females) and 100 control participants appeared to be healthy but were really between the ages of 5 and 70. We took 2 ml of blood from each patient and healthy person, placed it in an EDTA tube with 1 ml of Trizole as a preservative, and put the tubes in the freezer at -20 degrees Celsius until we were ready to analyze the samples. Recent studies prove the relationship between miR-124 and inflammatory processes and insulin resistance; our emphasis suggests the role miR-124 in insulin resistance in T2DM. Studies have explored the potential of miR-124 as a diagnostic biomarker for T2DM. Altered expression levels of these miRNAs have been detected in sera of newly T2DM-diagnosed patients, which promises to be a non-invasive technique for the disease. Regarding therapeutic scope, miR-124 may be used as a target for insulin sensitivity. Modulating this miRNA may have a potential therapeutic impact in managing T2DM. It is important to note that significant progress has been made in understanding the involvement of miR-124 in T2DM. New studies may provide additional knowledge on its mechanism to decrease insulin receptor resistance and beta cell function, hence, the pathophysiology of T2DM.
Publication Details
Page(s) 138-143
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Insulin resistance, Type 2 diabetes mellitus (T2DM), Diagnostic biomarkers, Circulating microRNAs, miRNA21, miRNA124
References
Whiting D. R.,Guariguata L.,Weil C.,Shaw J. .2011 .IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice, 94(3) : 311-21.
Chien H. Y.,Lee T. P.,Chen C. Y.,Chiu Y. H.,Lin Y. C.,Lee L. S.,Li W. C. .2015 .Circulating microRNA as a diagnostic marker in populations with type 2 diabetes mellitus and diabetic complications. Journal of the Chinese Medical Association, 78(4) : 204-11.
Sebastiani G.,Ventriglia G.,Stabilini A.,Socci C.,Morsiani C.,Laurenzi A.,Durairaj S. .2016 .Role of microRNA 21 in diabetes and associated/related diseases. Gene, 582 : 14-18.
Ross J. S.,Carlson J. A.,Brock G. .2007 .miRNA: the new gene silencer. American Journal of Clinical Pathology, 128(5) : 830.
Zhang W. H.,Jiang L.,Li M.,Liu J. .2023 .MicroRNA-124: an emerging therapeutic target in central nervous system disorders. Experimental Brain Research, 241(5) : 1215-1226.
Martinez-Sanchez A.,Rutter G. A.,Latreille M. .2017 .MiRNAs in β -cell development, identity, and disease. Frontiers in Genetics, 7 : 240782.
Baroukh N.,Ravier M. A.,Loder M. K.,Hill E. V.,Bounacer A.,Scharfmann R.,Van Obberghen E. .2007 .MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic β -cell lines. Journal of Biological Chemistry, 282(27) : 19575-19588.
Massart J.,Sjögren R. J.,Lundell L. S.,Mudry J. M.,Franck J. M.,O'Gorman D. J.,Krook A. .2017 .Altered miR-29 expression in type 2 diabetes influences glucose and lipid metabolism in skeletal muscle. Diabetes, 66(7) : 1807-1818.
Andrali S. S.,Sampley M. L.,Vanderford N. L.,Özcan S. .2008 .Glucose regulation of insulin gene expression in pancreatic β -cells. Biochemical Journal, 415(1) : 1-10.
Schultze S. M.,Jensen J.,Hemmings B. A.,Tschopp O.,Niessen M. .2011 .Promiscuous affairs of PKB/AKT isoforms in metabolism. Archives of physiology and biochemistry, 117(2) : 70-77.
Wojcik M.,Mac-Marcjanek K.,Wozniak L. A. .2009 .Physiological and pathophysiological functions of SIRT1. Mini reviews in medicinal chemistry. , 9(3) : 386-394.
Andrali S. S.,Sampley M. L.,Vanderford N. L.,Özcan S. .2008 .Glucose regulation of insulin gene expression in pancreatic β -cells. Biochemical Journal, 415(1) : 1-10.
Wang Z.,Nichols N. W.,Remedi C. G.,M. S. C. G. .2014 .Pancreatic β -cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell metabolism, 19(5) : 872-882.
Baroukh N. N.,Van Obberghen E. .2009 .Function of microRNA-375 and microRNA-124a in pancreas and brain. The FEBS journal, 276(22) : 6509-6521.
0

Citations

0

Downloads

20

Views